Loading...
Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems
Injectable implants with the ability to form in situ are one of the most promising carriers for the delivery of chemotherapeutic drugs to tumor sites. We have reported a novel injectable in situ-forming implant system composed of n-butyl-2-cyanoacrylate (NBCA), ethyl oleate, along with the sol-gel p...
Na minha lista:
| Udgivet i: | Drug Deliv |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7170320/ https://ncbi.nlm.nih.gov/pubmed/32212935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1745327 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|